Form 4 Filing for Anixa Biosciences Inc.

Arnold M. Baskies, a director at Anixa Biosciences Inc., reported a series of transactions on July 27, 2026. He exercised 6,000 stock options for common stock at a price of $0.00 per share, with an exercise price of $3.13 per share. This transaction resulted in the acquisition of 6,000 shares. Concurrently, 6,000 shares were disposed of, with 5,428 shares withheld by the company to cover the exercise price and associated costs. The disposal price was $3.46 per share. Following these transactions, Mr. Baskies holds 135,572 shares of common stock directly. The exercise of options was due to their expiration on August 23, 2026. The shares withheld for exercise costs were reported under footnote F1.